Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 10Active not recruiting 5Recruiting 4Terminated 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 4Breast Neoplasms 3Stomach Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Tongue Squamous Cell Carcinoma 1Squamous Non-Small Cell Lung Cancer SqNSCLC 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Resectable Esophageal Squamous Cell Carcinoma 1Rare Tumour 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Hypoxia 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1CLDN18.2 Positive 1Biliary Tract Neoplasms 1Advanced Non-squamous Non-small-cell Lung Cancer 1

Interventions

Cisplatin 9Radiotherapy 6Carboplatin 6toripalimab 5pembrolizumab 5Surgical Procedures, Operative 5Nivolumab 5Docetaxel 5Cetuximab 5Paclitaxel 4Drug Therapy 4Taxes 3Specimen Handling 3Magnetic Resonance Spectroscopy 3trilaciclib 2tislelizumab 2nimotuzumab 2camrelizumab 2Radiotherapy, Intensity-Modulated 2Injections 2Cyclophosphamide 2Blood Specimen Collection 2spartalizumab 1penpulimab 1fludarabine phosphate 1fludarabine 1dexamethasone-(C21-phosphoramide)-(anti-EGFR) 1dalpiciclib 1anlotinib 1Tea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Squamous Cell Carcinoma of Head and Neck × Albumin-Bound Paclitaxel × Clear all
NCT06647563 2024-10-18

Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 3 Not yet recruiting
355 enrolled
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡